NFKB1 and prostate cancer: Recently, a positive correlation between EMT transcription factors and NF-κB activation has been described in several human cancers [19]: breast cancer [20], prostate cancer [21], renal carcinoma [22], and head and neck squamous cell carcinomas [23].